What Treats Alzheimer’s Better? Leqembi or a Plant Based Diet?
June 11, 2024
Dr. Dean Ornish publishes the first trial investigating plant-based diets fighting or reversing early-stage Alzheimer’s. The results are eye-opening.
Search Results for: leqembi – Page 4
LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea
June 4, 2024
South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.
Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval
May 16, 2024
LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.
Carolyn Davis Talks About Her Leqembi Infusions
May 7, 2024
The newest and most promising drug to fight Alzheimer’s is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,
Leqembi for Alzheimer’s: Patient and Doctor Hopeful After First 6 Months
March 18, 2024
The first doses of the newly approved Alzheimer’s drug “Leqembi” were administered in Louisville. More than 100 people have signed up since then. See why.
Aduhelm for Alzheimer’s Discontinued. Is Leqembi Any Better?
February 8, 2024
Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.
Leqembi: An Alzheimer’s Drug Worth Rooting For?
November 16, 2023
At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease. Only five Alzheimer’s treatments have been approved by the FDA up until a
Alzheimer’s Drug Leqembi Gets Full FDA and MEDICARE Approval
July 7, 2023
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.
FDA Unanimously Votes Leqembi Benefits Alzheimer’s
June 11, 2023
The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s
Diranersen Hits Setback, Yet Marks Turning Point in Alzheimer’s Treatment
May 14, 2026
A Different Kind of Alzheimer’s Drug Just Delivered One of the Most Interesting Results in Years